Thanks for the tip. A website called cafepharma also makes an interesting use of twitter info to gauge increasing in popularity for pharma/biotech companies.
Sure, When I checked during the Summer Prana was not allowing a dividend reinvestment program (DRIP) to exist. Now they do.
If Prana were to issue a dividend today, per the DRIP program, the dividend would be additional shares of PRAN.
Personally I don't believe that it saved her life. I don't see how it could. No one can be denied care in the U.S. and there are heavily funded programs that already exist that cater to the un-insurable.
I thought this was strange. At the very end of June I set all my stocks that participated to be on a dividend reinvestment program. Only some allowed the option. I called Etrade at the time because the IAG I had just bought would not show up. As it turned out IAG had decided to not allow it for their July dividend.
Fast forward to today, I re-bought IAG (I sold it months ago, took the gain, and bought more PRAN) today I checked to see if a DRIP was an option for the December dividend. Much to my surprise PRAN showed up for the DRIP program so I selected it and later received an alert that it went through.
I can only surmise that Prana made some sort of change that would allow this. I'm not sure what the reason might be. Perhaps a preventative measure in case of building short interest? A stock dividend for the longs would be nice, but I won't hold my breath.
Sentiment: Strong Buy
Does someone need a tissue? I'd say it would be you who doesn't know much about LPC because the obvious answer to my question is there is no way to know how much they hold. They are private and do not disclose their holdings. I know because I've contacted them in the past. There are only 2 things that are certain, LPC is not holding 5% or more of the stock or they would have filed a 13D and per the agreement can't own more than 9.99%. But I would bet an educated long who has kept up on the financing, which started back in 2010, could venture a guess. Hopefully someone on here is more helpful than you.
I know quite a bit about LPC, and how many of the stocks they have been involved with have performed. Ask anyone in the industry about LPC, and they'll tell you this; companies end up there as a last resort. In Cytomedix defense many small caps are not faced with much other choice.
I have direct experience with LPC through another stock I've been involved with for a couple years that organized a financing deal with them. They went there after finding out that no IB's were interested. LPC has sold into every run the stock has had and probably shorts it on the way down. The nature of the beast. But it's better than going bankrupt.
I was disgusted to read that GOOG, RHT, and ORCL sent in busloads of engineers and programmers to speed up fixing that site.